Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial

British Journal of Cancer

Volumn 101, Issue 3, 2009, Pages 522-525

  Ahn, J ^a,b   Moore, S C ^a   Albanes, D ^a   Huang, W Y ^a   Leitzmann, M F ^c   Hayes, R B ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Aggressiveness; Height; Prostate cancer

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; EARLY CANCER; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE CANCER;

AGED; BODY HEIGHT; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK;

EID: 68149165789     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605159     Document Type: Article

References (29)

1. Ahn J, Moslehi R, Weinstein SJ, Snyder K, Virtamo J, Albanes D (2008) Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Int J Cancer 123: 1154-1159
2. Andersson SO, Wolk A, Bergstrom R, Adami HO, Engholm G, Englund A, Nyren O (1997) Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89: 385-389
3. Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB, Lubaroff DM, Wallace RB (1997) Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 8: 229-238
4. Clarke G, Whittemore AS (2000) Prostate cancer risk in relation to anthropometry and physical activity: the National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study. Cancer Epidemiol Biomarkers Prev 9: 875-881
5. Cox B, Sneyd MJ, Paul C, Skegg DC (2006) Risk factors for prostate cancer: a national case-control study. Int J Cancer 119: 1690-1694
6. Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 89: 1237-1242
7. Giovannucci E, Rimm EB, Liu Y, Willett WC (2004) Height, predictors of C-peptide and cancer risk in men. Int J Epidemiol 33: 217-225
8. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6: 557-563
9. Habel LA, Van Den Eeden SK, Friedman GD (2000) Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate 43: 136-143
10. Hebert PR, Ajani U, Cook NR, Lee IM, Chan KS, Hennekens CH (1997) Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 8: 591-597
11. Henderson BE, Ponder B, Ross RK (2003) Hormones, Genes, and Cancer. Oxford University Press: New York, NY
12. Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J, Xie T, Gao YT (2000) Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 9: 1335-1341
13. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5: 276-282
14. Macinnis RJ, English DR (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17: 989-1003
15. Macinnis RJ, English DR, Gertig DM, Hopper JL, Giles GG (2003) Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 12: 1417-1421
16. Nilsen TI, Vatten LJ (1999) Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men. Cancer Causes Control 10: 269-275
17. Norrish AE, McRae CU, Holdaway IM, Jackson RT (2000) Height-related risk factors for prostate cancer. Br J Cancer 82: 241-245
18. Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF, Tjonneland A, Severinsen MT, Overvad K, Rohrmann S, Kaaks R, Trichopoulou A, Zoi G, Trichopoulos D, Pala V, Palli D, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, May A, Manjer J, Wallstrom P, Stattin P, Hallmans G, Buckland G, Larranaga N, Chirlaque MD, Martinez C, Redondo Cornejo ML, Ardanaz E, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E (2008) Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 17: 3252-3261
19. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK (2000) Design of the prostate, lung, colorectal and Ovarian (PLCO) cancer screening trial. Control Clin Trials 21: 273S-309S
20. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey Jr JV, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schroder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry Jr CP, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149: 461-468
21. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ (2001) Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10: 345-353
22. Sequoia JS, Wright ME, McCarron P, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006) A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 15: 2174-2178
23. Severson RK, Grove JS, Nomura AM, Stemmermann GN (1988) Body mass and prostatic cancer: a prospective study. BMJ 297: 713-715
24. Silventoinen K, Sammalisto S, Perola M, Boomsma DI, Cornes BK, Davis C, Dunkel L, De Lange M, Harris JR, Hjelmborg JV, Luciano M, Martin NG, Mortensen J, Nistico L, Pedersen NL, Skytthe A, Spector TD, Stazi MA, Willemsen G, Kaprio J (2003) Heritability of adult body height: a comparative study of twin cohorts in eight countries. Twin Res 6: 399-408
25. Spencer EA, Appleby PN, Davey GK, Key TJ (2002) Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 5: 561-565
26. Tanner JM (1990) Foetus into Man. Physical Growth from Conception to Maturity. Harvard University Press: Cambridge
27. Veierod MB, Laake P, Thelle DS (1997) Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer 73: 634-638
28. Willett W (1998) Nutritional Epidemiology. Oxford University Press: New York, NY
29. Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M, Donovan J, Neal D, Hamdy F, Beynon R, Savovic J, Martin RM (2008) Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 17: 2325-2336